Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

Convalescent plasma (CP) is widely used to treat COVID-19, but without formal evidence of efficacy. Here, we report the beneficial effects of CP in a severely ill COVID-19 patient with prolonged pneumonia and advanced chronic lymphocytic leukemia (CLL), who was unable to generate an antiviral antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Honjo, Kazuhito, Russell, Ronnie M., Li, Ran, Liu, Weimin, Stoltz, Regina, Tabengwa, Edlue M., Hua, Yutao, Prichard, Lynn, Kornbrust, Ashton N., Sterrett, Sarah, Marques, Marisa B., Lima, Jose L., Lough, Chris M., McCarty, Todd P., Ketas, Thomas J., Hatziioannou, Theodora, Bieniasz, Paul D., Redden, David T., Moore, John P., Goepfert, Paul A., Heath, Sonya L., Hahn, Beatrice H., Davis, Randall S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817775/
https://www.ncbi.nlm.nih.gov/pubmed/33521696
http://dx.doi.org/10.1016/j.xcrm.2020.100164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7817775/
https://www.ncbi.nlm.nih.gov/pubmed/33521696
http://dx.doi.org/10.1016/j.xcrm.2020.100164

Ejemplares similares